Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 7589184, 10 pages
https://doi.org/10.1155/2017/7589184
Research Article

Medication Adherence Mediates the Association between Type D Personality and High HbA1c Level in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study

1School of Social Development and Public Policy, China Institute of Health, Beijing Normal University, Beijing 100875, China
2Clinics of Cadre, Department of Outpatient, General Hospital of the People’s Liberation Army (301 Hospital), Beijing 100853, China
3Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA
4Department of Sociology, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China

Correspondence should be addressed to Weijun Zhang; nc.ude.unb@jwz and Donghua Tian; moc.liamtoh@61256nait

Received 16 September 2016; Revised 23 November 2016; Accepted 7 December 2016; Published 9 February 2017

Academic Editor: Suat Simsek

Copyright © 2017 Xuemei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. V. Burkhart and E. Sabaté, “Adherence to long-term therapies: evidence for action,” Journal of Nursing Scholarship, vol. 35, no. 3, p. 207, 2003. View at Google Scholar · View at Scopus
  2. A. Liebl, A. Neiß, A. Spannheimer, U. Reitberger, T. Wagner, and A. Görtz, “Kosten des typ-2-diabetes in deutschland,” Deutsche Medizinische Wochenschrift, vol. 126, no. 20, pp. 585–589, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Osterberg and T. Blaschke, “Adherence to medication,” The New England Journal of Medicine, vol. 353, no. 5, pp. 487–497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Williams, R. C. O'Connor, N. Grubb, and R. O'Carroll, “Type D personality predicts poor medication adherence in myocardial infarction patients,” Psychology & Health, vol. 26, no. 6, pp. 703–712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Molloy, G. Randall, A. Wikman, L. Perkins-Porras, N. Messerli-Bürgy, and A. Steptoe, “Type D personality, self-efficacy, and medication adherence following an acute coronary syndrome,” Psychosomatic Medicine, vol. 74, no. 1, pp. 100–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Williams, R. C. O'Connor, S. Howard et al., “Type-D personality mechanisms of effect: the role of health-related behavior and social support,” Journal of Psychosomatic Research, vol. 64, no. 1, pp. 63–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. O. M. van de Ven, C. L. M. Witteman, and D. Tiggelman, “Effect of Type D personality on medication adherence in early adolescents with asthma,” Journal of Psychosomatic Research, vol. 75, no. 6, pp. 572–576, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. B. Pereira, M. H. Antoni, A. Danielson, T. Simon, J. Efantis-Potter, and M. J. O'Sullivan, “Inhibited interpersonal coping style predicts poorer adherence to scheduled clinic visits in human immunodeficiency virus infected women at risk for cervical cancer,” Annals of Behavioral Medicine, vol. 28, no. 3, pp. 195–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Curkendall, N. Thomas, K. F. Bell, P. L. Juneau, and A. J. Weiss, “Predictors of medication adherence in patients with type 2 diabetes mellitus,” Current Medical Research & Opinion, vol. 29, no. 10, pp. 1275–1286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Schiffer, O. R. F. Smith, S. S. Pedersen, J. W. Widdershoven, and J. Denollet, “Type D personality and cardiac mortality in patients with chronic heart failure,” International Journal of Cardiology, vol. 142, no. 3, pp. 230–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Aquarius, K. G. Smolderen, J. F. Hamming, J. De Vries, P. W. Vriens, and J. Denollet, “Type D personality and mortality in peripheral arterial disease: a pilot study,” Archives of Surgery, vol. 144, no. 8, pp. 728–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Diabetes Complications, http://www.diabetes.co.uk/diabetes-complications/diabetes-complications.html.
  13. Guide to HbA1c, http://www.diabetes.co.uk/what-is-hba1c.html.
  14. M. C. d'Emden, J. E. Shaw, P. G. Colman et al., “The role of HbA1c in the diagnosis of diabetes mellitus in Australia,” The Medical Journal of Australia, vol. 197, no. 4, pp. 220–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. World Health Organization, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 2011.
  16. American Diabetes A, “Standards of medical care in diabetes—2011,” Diabetes Care, vol. 34, supplement 1, pp. S11–S61, 2011. View at Google Scholar
  17. The Diabetes Control and Complications Trial Research Group, “Hypoglycemia in the diabetes control and complications trial,” Diabetes, vol. 46, no. 2, pp. 271–286, 1997. View at Publisher · View at Google Scholar
  18. UKPDS, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Li, S. Zhang, H. Xu et al., “Type D personality predicts poor medication adherence in Chinese patients with type 2 diabetes mellitus: a six-month follow-up study,” PLoS ONE, vol. 11, no. 2, Article ID e0146892, 2016. View at Publisher · View at Google Scholar
  20. F. E. P. Van Dooren, F. R. J. Verhey, F. Pouwer et al., “Association of Type D personality with increased vulnerability to depression: Is there a role for inflammation or endothelial dysfunction?—The Maastricht Study,” Journal of Affective Disorders, vol. 189, article no. 7711, pp. 118–125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Zhang, H. Xu, S. Zhao et al., “Prevalence and influencing factors of co-morbid depression in patients with type 2 diabetes mellitus: a General Hospital based study,” Diabetology & Metabolic Syndrome, vol. 7, no. 1, article 60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Zhang, H. Xu, S. Zhao et al., “Prevalence and influencing factors of co-morbid depression in patients with type 2 diabetes mellitus: a general hospital based study,” Diabetology and Metabolic Syndrome, vol. 7, no. 1, article no. 60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, H. Li, and S. Zou, “Association between cognitive distortion, type D personality, family environment, and depression in Chinese adolescents,” Depression Research and Treatment, vol. 2011, Article ID 143045, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K.-T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day, “Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk,” Annals of Internal Medicine, vol. 141, no. 6, pp. 413–420, 2004. View at Google Scholar · View at Scopus
  25. W. Jie, M. Yongzhen, and B. Rongwen, “Evaluation of reliability and validity of application of the Chinese version of 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes,” Chinese Journal of Diabetes, vol. 21, pp. 1101–1104, 2013. View at Google Scholar
  26. S. Firpo, N. Fortin, and T. Lemieux, Decomposing Wage Distributions Using Recentered Influence Function Regressions, University of British Columbia, 2007.
  27. B. J. Murawski, B. I. Chazan, M. C. Balodimos, and J. R. Ryan, “Personality patterns in patients with diabetes mellitus of long duration,” Diabetes, vol. 19, no. 4, pp. 259–263, 1970. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-J. Sheu, N.-C. Liu, L.-P. Ger et al., “High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 9, pp. 2087–2092, 2013. View at Publisher · View at Google Scholar
  29. S. S. Pedersen and J. Denollet, “Type D personality, cardiac events, and impaired quality of life: a review,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 10, no. 4, pp. 241–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Broström, A. Strömberg, J. Mårtensson, M. Ulander, L. Harder, and E. Svanborg, “Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS,” Journal of Sleep Research, vol. 16, no. 4, pp. 439–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Dieltjens, O. M. Vanderveken, D. Van den Bosch et al., “Impact of type D personality on adherence to oral appliance therapy for sleep-disordered breathing,” Sleep and Breathing, vol. 17, no. 3, pp. 985–991, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lehtonen and S. Pakarinen, “Right ventricular pacing-induced hypotension,” Heart, vol. 93, article 81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Denollet, “DS14: standard assessment of negative affectivity, social inhibition, and type D personality,” Psychosomatic Medicine, vol. 67, no. 1, pp. 89–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Denollet, C. J. Vrints, and V. M. Conraads, “Comparing Type D personality and older age as correlates of tumor necrosis factor-α dysregulation in chronic heart failure,” Brain, Behavior, and Immunity, vol. 22, no. 5, pp. 736–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. J. Molloy, L. Perkins-Porras, P. C. Strike, and A. Steptoe, “Type-D personality and cortisol in survivors of acute coronary syndrome,” Psychosomatic Medicine, vol. 70, no. 8, pp. 863–868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Williams, R. E. O'Carroll, and R. C. O'Connor, “Type D personality and cardiac output in response to stress,” Psychology & Health, vol. 24, no. 5, pp. 489–500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. M. C. Mommersteeg, J. Denollet, and E. J. Martens, “Type D personality, depressive symptoms and work-related health outcomes,” Scandinavian Journal of Public Health, vol. 40, no. 1, pp. 35–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. J. Pelle, A. A. Schiffer, O. R. Smith, J. W. Widdershoven, and J. Denollet, “Inadequate consultation behavior modulates the relationship between Type D personality and impaired health status in chronic heart failure,” International Journal of Cardiology, vol. 142, no. 1, pp. 65–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. V. M. Conraads, J. Denollet, L. S. De Clerck, W. J. Stevens, C. Bridts, and C. J. Vrints, “Type D personality is associated with increased levels of tumour necrosis factor (TNF)-α and TNF-α receptors in chronic heart failure,” International Journal of Cardiology, vol. 113, no. 1, pp. 34–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Gilmour and L. Williams, “Type D personality is associated with maladaptive health-related behaviours,” Journal of Health Psychology, vol. 17, no. 4, pp. 471–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Brownlee and I. B. Hirsch, “Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications,” The Journal of the American Medical Association, vol. 295, no. 14, pp. 1707–1708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. J. N. de Voogd, J. B. Wempe, K. Postema et al., “More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation?” Annals of Behavioral Medicine, vol. 38, no. 2, pp. 86–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. E. Maxwell and H. D. Delaney, “Bivariate median splits and spurious statistical significance,” Psychological Bulletin, vol. 113, no. 1, pp. 181–190, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Ferguson, L. Williams, R. C. O'Connor et al., “A taxometric analysis of type-D personality,” Psychosomatic Medicine, vol. 71, no. 9, pp. 981–986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Denollet, S. S. Pedersen, C. J. Vrints, and V. M. Conraads, “Predictive value of social inhibition and negative affectivity for cardiovascular events and mortality in patients with coronary artery disease: the type D personality construct,” Psychosomatic Medicine, vol. 75, no. 9, pp. 873–881, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Suls and J. Bunde, “Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions,” Psychological Bulletin, vol. 131, no. 2, pp. 260–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. T. W. Smith, “Toward a more systematic, cumulative, and applicable science of personality and health: lessons from type D personality,” Psychosomatic Medicine, vol. 73, no. 7, pp. 528–532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Denollet, “Type D personality: a potential risk factor refined,” Journal of Psychosomatic Research, vol. 49, no. 4, pp. 255–266, 2000. View at Publisher · View at Google Scholar · View at Scopus